Carbapenem Resistance among Gram Negative Bacilli in Lagos; Implications for Antimicrobial Stewardship.

Simple item page
dc.contributor.authorEttu, A.W
dc.contributor.authorOshun, P.O
dc.contributor.authorBode-Sojobi, I
dc.contributor.authorOduyebo, O.O
dc.date.accessioned2022-09-06T12:32:08Z
dc.date.available2022-09-06T12:32:08Z
dc.date.issued2018
dc.descriptionScholarly Publicationen_US
dc.description.abstractBackground: The emergence of carbapenemresistant Gram-negative bacilli (GNB) represents a serious public health threat which requires implementation of antimicrobial stewardship programs to reverse conditions that favour the emergence of multidrug-resistant GNB within the hospital (increased use of carbapenems), thereby reducing morbidity/mortality and healthcare costs. The prevalence of Carbapenem resistant GNB causing infections at LUTH and their resistance pattern to other classes of antimicrobial agents were determined. Methods: The bacterial isolates were recovered from various clinical specimens in LUTH between January and October 2015. Antimicrobial susceptibility testing was done using the Modified Kirby-Bauer disc diffusion and gradient diffusion methods and interpreted using EUCAST 2014 breakpoints tables, version 4.0 and CLSI 2013 guidelines Carbapenem resistance was defined as resistance to any of imipenem (10μg), meropenem (10 μg) or ertapenem (10 μg). Result: Four hundred and two Gram- negative bacilli were isolated. Seventy one (17.7%) were carbapenem resistant, comprising 16 (59.3%) of the 27 Acinetobacter baumanii, 26 (17%) of the 153 Pseudomonas aeruginosa, and 29 (17%) of the 222 Enterobacteriaece. All carbapenem resistant isolates were multidrug-resistant except one. Most isolates were susceptible to colistin (88 – 100%), polymixin B (88.5% for Pseudomonas aeruginosa), and tigecycline (44.1% for Enterobacteriaece). Four hundred and two Gram- negative bacilli were isolated. Seventy one (17.7%) were carbapenem resistant, comprising 16 (59.3%) of the 27 Acinetobacter baumanii, 26 (17%) of the 153 Pseudomonas aeruginosa, and 29 (17%) of the 222 Enterobacteriaece. All carbapenem resistant isolates were multidrug-resistant except one. Most isolates were susceptible to colistin (88 – 100%), polymixin B (88.5% for Pseudomonas aeruginosa), and tigecycline (44.1% for Enterobacteriaece).en_US
dc.identifier.citationEttu, A.W, Oshun, P.O., Bode-Sojobi, I., and Oduyebo, O.O. (2018). Carbapenem Resistance among Gram Negative Bacilli in Lagos; Implications for Antimicrobial Stewardship. Nig Qt J Hosp Med.; 28: 93 – 99.en_US
dc.identifier.issn0189-2657
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/11319
dc.language.isoenen_US
dc.publisherNigerian Quarterly Journal of Hospital Medicineen_US
dc.subjectCarbapenem resistance,en_US
dc.titleCarbapenem Resistance among Gram Negative Bacilli in Lagos; Implications for Antimicrobial Stewardship.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Carbapenem resistance in Gram negative bacilli.pdf
Size:
925.91 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical Microbiology and parasitology- Scholarly Publications